- ... considering changing this stance. It may allow for N-acetyl cysteine in dietary supplements as long as no safety issues come up. A final decision is pending. ...
- NLM Digital Collections - Congressional Black Caucus Health Braintrust (Washington, DC), 1992 Sep 25... therapy for HIV. Other investigations are evaluating the safety of N-acetyl-cysteine (NAC) and CDs pseugomonas exotoxin (sCD4-PE40) for ...
- NLM Digital Collections - Annual report - National Eye Institute (1974)Publication: [Bethesda, Md.] : National Eye Institute... study is designed to evaluate the efficacy and safety of n-acetyl-1-cysteine, a mucolytic agent in the treatment of the ...
- NLM Digital Collections - Policy regarding N-acetyl-L-cysteine : guidance for industryPublication: College Park, MD : Center for Drug Evaluation and Research, August 2022... 1.0 2022 Contains Nonbinding Recommendations Policy Regarding N-acetyl-L-cysteine: Guidance for Industry Additional copies are available from: Office of Dietary Supplement Programs, HFS-810 Center for Food Safety and Applied Nutrition Food and Drug Administration 5001 ...
- ... placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic ... RL, Hardan AY, et al. Safety and Efficacy of Memantine in Children with Autism: ...
- ... Hamamsy M, Bondok R, Shaheen S, et al. Safety and efficacy of adding intravenous N-acetylcysteine to parenteral L-alanyl-L-glutamine in hospitalized ...
- ... al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of ... B, et al. Renal safety and angiotensin II blockade medications in patients undergoing ...
- ... M, Radnia H, Farokhnia M, et al. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety. Clin Neuropharmacol. 2015 Jan–Feb;38(1):11– ...
- ... M, Radnia H, Farokhnia M, et al. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety. Clin Neuropharmacol. 2015 Jan–Feb;38(1):11– ...
- NLM Digital Collections - Oral medications inadvertently given via the intravenous routePublication: [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2013]... b. NIFEdipine strategies to prevent the inadver- c. Acetylcysteine tent IV administration of oral d. Megestrol acetate medications. Page 90 Pennsylvania Patient Safety Advisory Vol. 10, No. 3—September 2013 ©2013 ...
118 results